AI assistant
Sending…
RESMED INC — Director's Dealing 2013
Jun 5, 2013
30071_dirs_2013-06-05_4b7398d5-0007-488b-af55-c12a7b134eb1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-06-03
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-03 | ResMed Common Stock | M | 7500 | $21.025 | Acquired | 105480.678 | Direct |
| 2013-06-03 | ResMed Common Stock | S | 7500 | $47.960 | Disposed | 97980.678 | Direct |
| 2013-06-03 | ResMed Common Stock | S | 500 | $47.960 | Disposed | 97480.678 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-03 | ResMed Common Stock Options | $21.025 | M | 7500 | Disposed | 2014-11-07 | ResMed Common Stock (7500) | Direct |
Footnotes
F1: Trade executed pursuant to a 10b5-1 trading plan.
F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29